Milan researchers turn soybean byproduct into a 3D-printable material for skin-repair research
Researchers in Milan made a 3D-printable blend from okara, a soybean-processing residue, and the biodegradable polymer poly(ε-caprolactone). In laboratory tests, peptides extracted from okara showed antioxidant and anti-inflammatory activity and promoted migration of human dermal fibroblasts. The printed material retained those properties and released peptides over time, supporting further preclinical investigation for wound-care applications.
The story
A research collaboration involving the University of Milan, Politecnico di Milano and the NeMO Lab Research Center at Niguarda Hospital developed a bioactive material from okara, the residue left from making tofu and soy-based beverages. The researchers processed okara proteins into a hydrolysate containing bioactive peptides, then examined its effects on human dermal fibroblasts in vitro. According to the study report, the hydrolysate showed antioxidant and anti-inflammatory activity and promoted fibroblast migration, a process relevant to tissue repair. The team incorporated the hydrolysate into poly(ε-caprolactone), or PCL, a biocompatible and biodegradable polymer used in biomedical research. Mechanical, thermal and structural testing indicated that adding the hydrolysate preserved PCL’s main properties while allowing extended peptide release. The resulting blend could be 3D printed into complex structures, and the researchers reported that antioxidant, anti-inflammatory and pro-regenerative features remained after printing. The work was published in Communications Materials as part of the 3DBioPad project, which is exploring a pad for topical treatment of pain associated with breastfeeding and recovery after breast-cancer surgery.
Why it matters
Okara is commonly treated as a low-value byproduct despite retaining protein. This study identifies a possible use for that protein in a fabricated biomaterial rather than treating the residue only as waste. Combining a peptide-containing ingredient with 3D printing may also allow researchers to vary device geometry for particular anatomical needs. The practical consequence remains conditional: a material that can be manufactured in customized forms and releases peptides over time is a useful platform for testing, but it has not yet been shown to improve healing or relieve pain in people.
Evidence and context
The research joins two technical objectives that are often assessed separately: using food-processing residues and designing materials for biomedical applications. Okara provided the peptide source, while PCL supplied the printable polymer matrix. The source describes the project as integrating mechanical design, materials science, food and pharmaceutical sciences, product design and additive manufacturing; that combination matters because a topical device must be both manufacturable and suitable for biological testing. The reported measurements covered material properties, peptide release and cell-based responses, rather than only the chemical extraction of useful compounds. The authors also demonstrated that printing did not remove the reported bioactive features, addressing a practical question for a material intended to be shaped into devices.
Limits and unknowns
The evidence is currently limited to in-vitro experiments with human dermal fibroblasts and laboratory characterization of the blend. It does not establish safety on intact or damaged skin, effectiveness in healing wounds, pain relief, biodegradation in the body, or performance in animal or human studies. The source also does not provide clinical dosing, comparison with existing wound-care materials, manufacturing cost, or long-term storage data. A stated next step is to print a biomimetic breast-skin phantom, which may test behavior in a more tissue-relevant setting but will still precede later validation phases.
Follow the story
Share it, watch the explainer, or continue with the reporting trail.
Milan researchers turn soybean byproduct into a 3D-printable material for skin-repair research
A short visual explainer for readers who want the story in a different rhythm.
Highlights
- A printable blend from soy leftovers
- Okara extract meets biodegradable polymer
- Activity remained after printing
- A possible use for topical pads
Transcript
Milan researchers have made a 3D-printable blend from okara, a soy byproduct, for skin-repair research.
Researchers at Milan universities and NeMO Lab mixed peptide-rich okara extract into biodegradable polymer PCL.
Lab tests found printed structures kept antioxidant and anti-inflammatory activity while releasing peptides over time.
If validated, topical pads could help people with breastfeeding pain or pain after breast-cancer surgery.
Next, they'll print a breast-skin model; healing and pain relief in people remain untested.